Hydroxychloroquine has evolved from a sleepy anti-malarial drug into a partisan litmus test over the future of COVID-19 treatment. Dan and Axios health care reporter Bob Herman dig into what we know about the drug, what we still don't, and why both matter.
Jack Dorsey, Bill Gates and other billionaires are pledging big money to address the coronavirus crisis. But as billionaires do good, do they become too powerful? Dan digs in with Recode reporter Teddy Schleifer.
